DRIVE is looking for new startups – application deadline August 26

In the incubator DRIVE, you can build your Life Science startup in a unique environment. Now they are looking for new startups and the deadline for applications is August 26.

DRIVE is KI Innovation’s business incubator with a focus on life science and health. As a member of the incubator, companies gain access to KI Innovation’s broad network within the life science industry, healthcare, investors and experts with various expertise. DRIVE welcomes both life science startup companies born from ideas validated in KI Innovation’s START program, but the incubator is also open to other newly started KI or non-KI related research-based companies in life science and digital health.

Membership is free of charge, DRIVE is financed by Karolinska Institutet and partners as well as Vinnova´s Excellence programme.

Read more at KI Innovations
Read more about the application process

South Korean Game Investors Visited Press Start Game Hub in Flemingsberg

A delegation of investors from some of South Korea’s leading game companies visited Press Start Game Hub in Flemingsberg yesterday, a growing hub for game innovation and entrepreneurship in Europe. The visit was part of an initiative organized by Business Sweden, aimed at strengthening ties between the Swedish and South Korean gaming industries.

The Flemingsberg Science Foundation welcomes Angela Hoyer as the new Networks and Event Manager

With a background as a researcher at Karolinska Institutet and experience from academia, industry, and networking, Angela Hoyer, the new Networks and Event Manager at the Flemingsberg Science Foundation, is passionate about developing the life science sector. In her new role, Angela looks forward to creating meeting places where collaborations can grow, while also contributing to Flemingsberg’s continued development as a strong international hub for research and innovation.

A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated

With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.

Do you want to know more?
Subscribe to our newsletter.

Do you want to know more?
Subscribe to our newsletter.

CF_logo_neg
2022-08-11T16:27:12+02:00
Go to Top